Journals in Molecular neuroscience

Current Opinion in Neurobiology

ISSN: 0959-4388
5 Year impact factor: 5.7
Impact factor: 4.8

Current Opinion in Neurobiology publishes short annotated reviews by leading experts on recent developments in the field of neurobiology. These experts write short reviews describing recent discoveries in this field (in the past 2-5 years), as well as highlighting select individual papers of particular significance.The journal is thus an important resource allowing researchers and educators to quickly gain an overview and rich understanding of complex and current issues in the field of Neurobiology. The journal takes a unique and valuable approach in focusing each special issue around a topic of scientific and/or societal interest, and then bringing together leading international experts studying that topic, embracing diverse methodologies and perspectives.Journal Content: The journal consists of 6 issues per year, covering 8 recurring topics every other year in the following categories:Neurobiology of DiseaseNeurobiology of BehaviorCellular NeuroscienceSystems NeuroscienceDevelopmental NeuroscienceNeurobiology of Learning and PlasticityMolecular NeuroscienceComputational NeuroscienceIn addition, every year 2 issues are allocated to Hot Topics. Section Editors, who are major authorities in the field, are appointed by the Editors-in-Chief of the journal to commission reviews from experts on each topic that they have selected. Review articles in Current Opinion in Neurobiology are by invitation only.The journal is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion title to the primary research, open access journal, Current Research in Neurobiology . CO+RE journals leverage the?Current Opinion?legacy of editorial excellence, high-impact, and global reach which ensures they are a widely-read resource, integral to a scientist?s workflow.

FEBS Letters

ISSN: 0014-5793

FEBS Letters is one of the world's leading journals in biochemistry and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, hypotheses and research letters that merit urgent publication.FEBS Letters offers: • Faster publication: − Accepted articles are published online in 3 days − The print version of the article is published in 3 to 5 weeks after acceptance • Full-text article disclosure in HTML and PDF formats • Articles in Press are included in PubMed • Easy online manuscript submission system • Transparent online peer review and manuscript tracking system • No page charges • Free color figuresSubject Coverage: The subject area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism, and immunochemistry), structural biology, biophysics, computational biology (genomics, proteomics, bioinformatics), molecular genetics, molecular biology and molecular cell biology (signal transduction, intracellular traffic, regulation of cellular proliferation, cell-cell interactions) and systems biology. Studies on microbes, plants and animals at the molecular level are within the scope of FEBS Letters.Submitting Authors: Manuscripts can be submitted to FEBS Letters at: http://ees.elsevier.com/febsletters/

Journal of Physiology - Paris

ISSN: 0928-4257

Each issue of the Journal of Physiology (Paris) is specially commissioned, and provides an overview of one important area of neuroscience, delivering review and research papers from leading researchers in that field. The content will interest both those specializing in the experimental study of the brain and those working in interdisciplinary fields linking theory and biological data, including cellular neuroscience, mathematical analysis of brain function, computational neuroscience, biophysics of brain imaging and cognitive psychology.This is also a forum where the proceedings of specialized symposia can be published as a collection of full-length articles and the https://www.journals.elsevier.com/journal-of-physiology-paris/editorial-board/Editor-in Chief welcomes suggestions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our https://www.elsevier.com/authors/author-servicesauthor services.Please see our https://www.elsevier.com/journals/journal-of-physiology-paris/0928-4257/guide-for-authorsGuide for Authors for information on article submission. If you require any further information or help, please visit our https://service.elsevier.com/app/home/supporthub/publishing/Support Center

Molecular and Cellular Neuroscience

ISSN: 1044-7431
5 Year impact factor: 3.3
Impact factor: 2.6

Molecular and Cellular Neuroscience publishes original research of high significance covering all aspects of neurosciences indicated by the broadest interpretation of the journal's title. In particular, the journal focuses on synaptic maintenance, de- and re-organization, neuron-glia communication, and de-/regenerative neurobiology. In addition, studies using animal models of disease with translational prospects and experimental approaches with backward validation of disease signatures from human patients are welcome.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.

Neurochemistry International

ISSN: 0197-0186
5 Year impact factor: 3.8
Impact factor: 4.4

The Journal of Cellular and Molecular NeuroscienceNeurochemistry International is devoted to the rapid publication of outstanding original articles and timely reviews in neurochemistry. Manuscripts on a broad range of topics will be considered, including molecular and cellular neurochemistry, neuropharmacology and genetic aspects of CNS function, neuroimmunology, metabolism as well as the neurochemistry of neurological and psychiatric disorders of the CNS.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.

Neuropeptides

ISSN: 0143-4179
5 Year impact factor: 2.5
Impact factor: 2.5

The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems.The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editor, to avoid possible duplication.

Neuropharmacology

ISSN: 0028-3908
5 Year impact factor: 4.5
Impact factor: 4.6

Neuropharmacology publishes high quality, original research within the discipline of neuroscience. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. Work with non-mammalian and invertebrate species may be considered in exceptional circumstances. The journal does not usually accept clinical research, although neuropharmacological studies in humans may be considered on the condition that they provide novel insight into either the actions of drugs and/or neurobiological mechanisms. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Similarly, manuscripts describing the use of natural products will only be considered if the active ingredient is known and disclosed.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.Neuropharmacology also publishes topical narrative reviews on subjects within its remit. These reviews are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief of their intention to submit a review. Potential review authors should clearly indicate in the cover letter their expertise in the area, the timeliness of the topic, and how the review differs from, and adds to, recent published reviews on related topics. Authors are expected to have an established experimental track record in the topic of the review, and should provide full citations, including URLs/DOIs, of recent experimental papers in peer-reviewed journals relevant to the topic of the review in their cover letter. In the absence of an experimental track record, authors should provide a justification for why they believe they are the right persons to author this review article at this point in time. The absence of any such evidence of relevant experimental expertise or an explanation of author appropriateness will result in the return of the manuscript to the authors. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a prompt decision regarding the proposed review. Systematic reviews, meta- or bibliographic analyses will not be considered unless they are a necessary part of a Special Issue and conducted by experts in the field, and even then only under exceptional circumstances and at the discretion of the Editor-in-Chief.

Neuroscience

ISSN: 0306-4522
5 Year impact factor: 3
Impact factor: 2.9

Neuroscience is the official journal of the International Brain Research Organization (IBRO). Founded in 1976, Neuroscience is IBRO’s flagship journal and its profits support IBRO's numerous international initiatives for investigators at all career stages and the neuroscience community worldwide. Neuroscience publishes high-quality peer-reviewed articles on fundamental science, meta-analyses, clinical studies, and reviews focused on the scientific study of the central, peripheral, and enteric nervous systems. As an international, interdisciplinary journal, Neuroscience covers research in molecular, cellular, developmental, systems, behavioural, cognitive and computational neuroscience.Neuroscience and IBRO are committed to promoting diversity, equity, and inclusion in all aspects of the journal. We strongly encourage consideration of diversity in authorship teams and article references. Additionally, we require robust justification for the choice of sex and gender in cellular and animal models, as well as in patient inclusion/exclusion criteria in clinical trials or sample collection. Research areas include, but are not limited to:The central, peripheral, and enteric nervous systems, including neuroscience related to the brain, retina, spinal cord, and gut-brain axis.The neuroscience of physiological processes encompassing all life stages (development, adulthood, aging) and related to multiple conditions, including infection, memory, neuroimmunology, pain, addiction, reward, stress, and synaptic plasticity.Neurological diseases and disorders, such as Alzheimer’s disease, autism spectrum disorder, deafness, mood disorders, epilepsy, Huntington’s disease, Parkinson’s disease and stroke.Neuroinflammation, including the role of microglia, astrocytes, and other non-neuronal nervous system cell types. Neuroscience related to the understanding of cognition, emotion, and behaviour. Neuroscience-related techniques and technologies, including artificial intelligence, computational neuroscience, electrophysiology, optogenetics, and neural imaging. Neuroscience-related therapeutics, including pharmaceutical interventions, exercise, nutrition, neuroscience reprogramming, stem cell therapy, transcranial magnetic stimulation. Reviews: We welcome unsolicited reviews that offer new insights, perspectives, or opinions on a controversy or innovation in the field. Reviews that merely reiterate background information will not be accepted.

Progress in Neurobiology

ISSN: 0301-0082
5 Year impact factor: 8.7
Impact factor: 6.7

Progress in Neurobiology is an international journal that publishes groundbreaking original research, comprehensive review articles and opinion pieces written by leading researchers. The journal welcomes contributions from the broad field of neuroscience that apply neurophysiological, biochemical, pharmacological, molecular biological, anatomical, computational and behavioral analyses to problems of molecular, cellular, developmental, systems, and clinical neuroscience.Research categoriesBasic Research: Research addressing the fundamental principles, mechanisms, and basic neurobiological processes that underlie the nervous system.Disease-related: Research related to neurological diseases or disorders, including disease-related basic research (involving animal and cell models), translational research, and clinical research.

Trends in Neurosciences

ISSN: 0166-2236
5 Year impact factor: 15
Impact factor: 14.6

For over four decades, Trends in Neurosciences (TINS) has been a prominent source of inspiring reviews and commentaries across all disciplines of neuroscience. TINS is a monthly, peer-reviewed journal, and its articles are curated by the Editor and authored by leading researchers in their respective fields. The journal communicates exciting advances in brain research, serves as a voice for the global neuroscience community, and highlights the contribution of neuroscientific research to medicine and society.Visit the Cell Press website for more information about Trends in Neurosciences - http://www.cell.com/trends/neurosciences/home

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health